Cited by 7Bone Metabolism and DiseasesAlkaline Phosphatase Research StudiesBone health and osteoporosis research

Reduction of protein phosphatase 2A Cα promotes in vivo bone formation and adipocyte differentiation

Yoshida, Kaya, Teramachi, Jumpei, Uchibe, Kenta, Ikegame, Mika, Qiu, Lihong, Yang, Di, Okamura, Hirohiko·2018·Molecular and Cellular Endocrinology

Abstract

Serine/threonine protein phosphatase 2A (PP2A) regulates diverse physiological processes such as cell cycle, growth, apoptosis, and signal transduction. Previously, we demonstrated that silencing of the α-isoform of PP2A catalytic subunit (PP2A Cα) in osteoblasts accelerated osteoblast differentiation, whereas its overexpression suppressed differentiation. In this study, we examined the role of PP2A Cα in in vivo bone formation by generating transgenic mice (PP2A-Tg), in which the dominant negative form of PP2A Cα was specifically expressed in osteoblasts. PP2A-Tg mice exhibited an increase in body weight, cortical bone mineral density, and cortical bone thickness. Interestingly, they also displayed higher amounts of adipose tissue in the bone marrow of tibiae. The co-culture study showed that PP2A Cα-knockdown osteoblasts stimulated adipocyte differentiation from undifferentiated mesenchymal cells via upregulation of the adipocyte marker genes, such as peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα). These results indicated that the reduction of PP2A Cα levels in osteoblasts promoted bone formation in vivo. Additionally, PP2A Cα in osteoblasts was also potentially involved in controlling adipocyte differentiation through a paracrine mechanism.

Integrity signals

Registry

Crossref · 10.1016/j.mce.2017.11.005

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Osteoblast-specific overexpression of the dominant-negative L199P Cα mutant causes a 50% overall decrease in PP2A activity and is associated with larger and heavier mice.

    “In bone, osteoblast-specific overexpression of the dominant-negative L199P Cα mutant, caused a 50% overall decrease in PP2A activity, associated with larger and heavier mice [96].”
  • The increased bone marrow adipogenesis in L199P Cα mice is suspected to be caused by a paracrine mechanism.

    “In addition, in the bone marrow, increased adipogenesis was observed, suspected to be caused by a paracrine mechanism.”
  • In these mice, bone mineral density and thickness are significantly increased, while cartilage thickness is not affected.

    “In the animals, bone mineral density and thickness were significantly increased, while cartilage thickness was not affected.”
  • In the bone marrow of L199P Cα mice, increased adipogenesis is observed.

    “In addition, in the bone marrow, increased adipogenesis was observed, suspected to be caused by a paracrine mechanism.”

The citation lists haven’t been fetched yet

References 38 · Cited by 7

Authors
Yoshida, K., Teramachi, J., Uchibe, K., Ikegame, M., Qiu, L., Yang, D., & Okamura, H.
Affiliations
  • Tokushima University (JP)
  • Okayama University (JP)
  • China Medical University (CN)
Corresponding author
  • Yang, Di
  • Okamura, Hirohiko
Venue
Molecular and Cellular Endocrinology
Publisher
Elsevier BV
Published
2018-07
Volume
470
Pages
251-258
ISSN
0303-7207 (ISSN-L)
OpenAlex
W2768029280
Cited by
7
References
38
Citations by year
2025: 3 · 2021: 1 · 2020: 1 · 2018: 2
FWCI
0.34
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular and Cellular Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology (23592703)
  • Takeda Science Foundation
  • Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (17KI255)
  • Nakatomi Foundation
  • Japan-China Medical Association
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
protein phosphatase 2A, bone formation, osteogenic differentiation, adipogenesis, bone marrow adipocytes, PPARγ, C/EBPα, paracrine signaling, mesenchymal cells, cortical bone mineral density, transgenic mice
MeSH terms
Cortical Bone, Animals, Cell Differentiation, Cell Line, Mice, Transgenic, Osteoblasts, Osteogenesis, Biomarkers, Bone Density, Up-Regulation, Adipocytes, Collagen Type I, Adipogenesis, Protein Phosphatase 2, Gene Knockdown Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review